In part 5 of this Exclusive Interview, Dr. Thomas Seck talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about costs and benefits of Empagliflozin for patients as well as insurance companies.
Read More »Thomas Seck Part 6, Cardiovascular Disease and Type 2 Diabetes
In part 6 of this Exclusive Interview, Dr. Thomas Seck talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the impact of heart disease on the patient with diabetes.
Read More »Thomas Seck Part 7, The Future For Boehringer Ingelheim
In part 7 of this Exclusive Interview, Dr. Thomas Seck talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about what's coming up next for Boehringer Ingelheim and knowing the right patient to treat with the newest drugs.
Read More »Thomas Seck Part 8, Empagliflozin Effects On Prediabetes
In part 8 of this Exclusive Interview, Dr. Thomas Seck talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about plans to study the effects of Empagliflozin in patients with prediabetes.
Read More »Thomas Seck Part 9, Final Thoughts
In part 9, the conclusion of this Exclusive Interview, Dr. Thomas Seck talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the importance of adding diet and exercise to a treatment regimen.
Read More »Jamie Uribarri Current Interview
Dr. Jaime Uribarri is a physician and clinical investigator. He was born in Chile and received his medical degree from the University of Chile School of Medicine. He did all his postgraduate training in the United States. He has been in The Icahn School of Medicine at Mount Sinai, NYC, since 1990, where he is currently Professor of Medicine and Director of the Renal Clinic and the Home Dialysis Program at the Mount Sinai Hospital.
Read More »Jamie Uribarri Transcript
In this exclusive interview transcript, Dr. Jamie Uribarri discusses his research into Advanced Glycation Endproducts (AGEs) in food, the role they play in overall health, and how to achieve lower AGE diets through food choices and cooking techniques.
Read More »Jamie Uribarri Full Interview
In this Exclusive Interview, Dr. Jamie Uribarri talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about his research into AGEs (Advanced Glycation Endproducts) in food, how AGEs affect health and contribute to diseases like diabetes, and how people can lower AGEs in their diets through food choices and cooking techniques.
Read More »Jamie Uribarri Part 1, High AGE Versus Low AGE Diet
In part 1 of this Exclusive Interview, Jamie Uribarri talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the compounds called Advanced Glycation Endproducts (AGE) in food, and the benefits of a low AGE diet.
Read More »Jamie Uribarri Part 2, Foods With A High AGE
In part 2 of this Exclusive Interview, Jamie Uribarri talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about low AGE versus high AGE diets, and why cooking methods are key to avoiding foods with a high AGE.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.